MetLife, Inc. filings document the regulatory record of a Delaware financial services company with NYSE-listed common stock and preferred securities, including depositary shares tied to Series E and Series F preferred stock. Recent Form 8-K reports furnish earnings releases, quarterly financial supplements, total assets under management fact sheets and Regulation FD disclosures related to variable investment income.
The filings also cover capital-structure actions such as subordinated debenture issuance and preferred stock dividend declarations. Proxy materials describe board composition, committee assignments, executive compensation and shareholder voting matters, while material-event reports record governance changes and other corporate disclosures.
MetLife Inc. executive Ramy Tadros reported a tax-related share disposition. On this Form 4, 5,166 shares of MetLife common stock were withheld on March 2, 2026 at $73.24 per share to cover taxes on shares issued from restricted stock units. After this withholding, Tadros directly holds 216,819 MetLife shares.
MetLife Inc.'s Executive Vice President and Chief Legal Officer, Monica M. Curtis, reported a tax-related share disposition on a Form 4. On March 2, 2026, 953 shares of MetLife common stock were withheld at $73.24 per share to cover taxes on shares issued from restricted stock units. After this tax-withholding disposition, she directly owned 17,646 shares of MetLife common stock.
MetLife (MET) reported proposed sales of Common Stock under a Form 144 filing. The notice lists multiple transactions dated between 12/17/2025 and 01/09/2026, with example recent sales including 562 shares on 01/09/2026 and 359 shares on 12/19/2025.
MetLife Inc. President, U.S. Business, Ramy Tadros reported stock-based compensation activity. He received 19,910 restricted stock units under a 2025 stock and incentive plan and 23,006 common shares from a 2023–2025 performance share award, deferring 80% of that payout. To cover taxes on the performance share payout, 2,299 shares were withheld at a price of $75.34 per share. After these awards and tax withholding, he directly owns 221,985 MetLife common shares.
MetLife, Inc. reported a director stock award. Non-management director Michelle Seitz acquired 273 shares of MetLife common stock on a grant basis, with a reported price of $0.00 per share.
After this award, she directly holds 273 common shares, reflecting compensation paid in stock under MetLife’s non-management director fee arrangements.
MetLife Inc. EVP & Chief Risk Officer Marlene Debel reported equity compensation transactions in company common stock. On February 24, 2026, she acquired 15,132 shares at no cost as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan and 14,870 shares from the performance-based payout of a 2023–2025 performance share award.
On the same date, 5,624 shares at $75.34 per share were withheld to cover her tax obligations related to the performance share payout. After these transactions, she directly owned 158,513 MetLife common shares. These movements reflect stock-based compensation and related tax withholding, not open‑market buying or selling.
MetLife Inc EVP & Chief Legal Officer Monica M. Curtis reported equity awards and related tax withholding transactions in company stock. On February 24, 2026, she received a grant of 7,964 shares of common stock as a restricted stock unit award under MetLife’s 2025 Stock and Incentive Compensation Plan.
She also acquired 420 shares of common stock from the performance-based payout of a 2023–2025 performance share award under MetLife’s 2015 Stock and Incentive Compensation Plan. To cover taxes on this performance share payout, 237 shares were withheld at a price of $75.34 per share. After these transactions, her directly held common stock position was reported at 18,599 shares.
MetLife Inc. executive Bill Pappas reported equity awards and related tax withholding transactions in company stock. On February 24, 2026, he acquired 20,508 and 22,866 shares of MetLife common stock at $0 per share through stock awards, and 11,683 shares were withheld at $75.34 per share to cover tax obligations. After these transactions, he directly owned 89,735 shares. The filing also notes additional indirect holdings of 10,220 and 18,750 shares through 2024 and 2025 Grantor Retained Annuity Trusts.
O'Neill Adrienne Karen reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc executive Adrienne Karen O'Neill, EVP & Chief Accounting Officer, received an equity grant of 2,655 shares of common stock on February 24, 2026. The shares were awarded at $0.00 per share as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing her directly owned holdings to 14,557 shares.
Sibblies Shurawl reported acquisition or exercise transactions in this Form 4 filing.
MetLife Inc executive Sibblies Shurawl received an equity award of 6,372 shares of common stock on February 24, 2026. The shares were granted at a price of $0.00 per share as a restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, increasing Shurawl’s direct holdings to 28,256 shares.